Mycobutin · DIN 02063786 · 150 mg · capsule
Limited Use, Reason for Use code 103, 104 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 103, 104 required
Write on scriptone applicable Reason for Use code, 103 or 104 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 103, 104
Coverage limit:
For the prevention of Mycobacterium Avium Intracellular (MAI) in:
Reason for Use code 103
Patients with a CD4+ cell count less than 200/mm3 with an AIDS-defining diagnosis;
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 104
Patients with a CD4+ cell count less than 100/mm3 without an AIDS-defining diagnosis.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Mycobutin · DIN 02063786
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2005-02-16 · brand MYCOBUTIN · ATC J04AB04 RIFABUTIN · form Capsule · route Oral · ingredients RIFABUTIN 150 MG · company Atlantic nanofend group ltd. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordMycobutin: Formulary list price $6.33 per unit (the source does not state the unit; exact figure $6.3342). What the ministry pays, not the patient.
Ministry pays: $6.3342 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02063786)
Source record
DIN 02063786: Mycobutin
Raw flags: sec12=Y, sec3=Y
Item: 081600018; group id 56; item number 0114; lccId 00005; manufacturer id PFI
Source form: Cap; strength: 150mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $6.3342; ministry $6.3342
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02063786
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18081
Shortage status: resolved shortage (ended April 8, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02063786
Shortage record checked October 6, 2026